Latest News
ZeNix trial shows lower dose of linezolid can be used for treating highly drug resistant tuberculosis
Results from the ZeNix trial show that the BPaL combination of drugs remains effective against highly drug resistant tuberculosis (TB) with reduced dosage or duration of the linezolid part of the regimen.
ODYSSEY trial finds dolutegravir-based HIV treatment is better for babies
The anti-HIV drug dolutegravir, given in combination with other anti-HIV drugs, improves outcomes for babies and young children living with HIV, compared to standard anti-HIV treatment combinations.
UNITE4TB partnership launches
Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
New results confirm the benefit of arthritis drugs in hospitalised patients with COVID-19
New results confirm the benefit of arthritis drugs in hospitalised patients with COVID-19